JNJ-5207852 dihydrochloride

CAS No. 1782228-76-5

JNJ-5207852 dihydrochloride( —— )

Catalog No. M22976 CAS No. 1782228-76-5

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2 nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13 mg kg 1, subcutaneously.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 65 Get Quote
5MG 93 Get Quote
10MG 163 Get Quote
25MG 327 Get Quote
50MG 485 Get Quote
100MG 700 Get Quote
500MG 1458 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JNJ-5207852 dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2 nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13 mg kg 1, subcutaneously.
  • Description
    JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2 nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13 mg kg 1, subcutaneously. It promotes wakefulness in rodents at 10 mg kg 1 s.c. but not at 1 mg kg 1, and significantly, this effect was absent in H3 receptor KO mice. JNJ-10181457 is also a dibasic amine antagonist that exhibits high-affinity binding for the rat H3 receptor (Ki=7.1 nm), promoting wakefulness in rodents and reducing cataplectic attacks in narcoleptic dogs . JNJ-10181457 improved cognitive performance in SHR pups at 10 mg kg 1.
  • In Vitro
    ——
  • In Vivo
    JNJ-5207852 (1-10mg/kg s.c.) increases time spent awake and decreases REM sleep and slow-wave sleep, but fails to have an effect on wakefulness or sleep in H3 receptor knockout mice. The wake promoting effects of this H3 receptor antagonist are not associated with hypermotility. A 4-week daily treatment of mice with JNJ-5207852 (10 mg/kg i.p.) does not lead to a change in body weight. JNJ-5207852 is extensively absorbed after oral administration and reaches high brain levels. Animal Model:Male, Sprague-Dawley ratsweighing 282-334 g.Dosage:3, 10, 30 mg/kg.Administration:S.C. Result:Iincreased time spent awake and decreased REM sleep and slow-wave sleep.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1782228-76-5
  • Formula Weight
    389.4
  • Molecular Formula
    C20H34Cl2N2O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H]Cl.[H]Cl.N1(CCCOC2=CC=C(CN3CCCCC3)C=C2)CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Esbenshade T A , Browman K E , Bitner R S , et al. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders[J]. 2008, 154(6):1166-1181.
molnova catalog
related products
  • 3-Hydroxyflavone

    3-hydroxyflavone is a member of the class of compounds known as flavonols. 3-hydroxyflavone can be found in a number of food items such as brassicas, pomegranate, red raspberry, and fenugreek. 3-hydroxyflavone is a chemical compound.

  • Pyrilamine maleate

    A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally.

  • Triprolidine hydroch...

    Histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria.